Leaflet DOLNADA 40mg / 20mg prolonged-release tablets

Product code:
W63817010
Quantity:
100
Indicated for:
moderate to severe pain
Route of administration:
oral
Substance:
oxycodone + naloxone (opioid analgesic + opioid antagonist)
ATC
N02AA55 — Nervous system | Opioids | Natural opium alkaloids

Precautions:

Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Dependence / abuse

This medicine may cause dependence or be misused.

Respiratory depression

May slow breathing, especially with alcohol or sedatives.

Avoid alcohol

Avoid alcohol during treatment.

Major drug interactions

This medicine may have important interactions with other medicines.

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

Elderly warning

Older people may have an increased risk of side effects.

Withdrawal / do not stop abruptly

Do not stop treatment abruptly without medical advice.

Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

The combination of oxycodone and naloxone is used for the treatment of severe pain requiring continuous opioid analgesic administration. Oxycodone is a potent opioid analgesic, while naloxone is an opioid antagonist that reduces the risk of opioid-induced constipation.

The medication is taken orally, usually as extended-release tablets, as directed by your doctor. It is important to follow the prescribed dosage to avoid the risk of dependence or other adverse effects.

Side effects may include nausea, drowsiness, dizziness, constipation, or, in rare cases, respiratory depression.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as respiratory or liver diseases, to ensure the safe use of this combination.

General data about DOLNADA 40mg / 20mg

Substance:
oxycodone + naloxone
Date of latest medicines list:
01-12-2023
Product code:
W63817010
Concentration:
40mg / 20mg
Pharmaceutical form:
prolonged-release tablets
Quantity:
100
Product type:
Generic medicine
Prescription status:
TAB2 — Medicines dispensed with a special medical prescription for narcotic substances, yellow in color.

Marketing authorisation

Manufacturer:
KRKA, D.D., NOVO MESTO - SLOVENIA
Holder:
KRKA, D.D., NOVO MESTO - SLOVENIA
Number:
10099/2017/10
Shelf life:
18 months

Pharmaceutical forms available for oxycodone + naloxone

Concentrations available for oxycodone + naloxone

  • 10mg/5mg
  • 15mg/7.5mg
  • 2.5mg/1.25mg
  • 20mg/10mg
  • 30mg/15mg
  • 40mg/20mg
  • 5mg/2.5mg
  • 60mg/30mg
  • 80mg/40mg